Financials Coretag, Inc.

Equities

JMKJ

US65444P2002

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 14:54:52 06/07/2021 BST 5-day change 1st Jan Change
12,500 USD -80.77% Intraday chart for Coretag, Inc. -.--% -.--%

Valuation

Fiscal Period: September 2020 2021 2022 2023
Capitalization 1 50 375 1,125 1,125
Enterprise Value (EV) 1 50 375 1,125 1,125
P/E ratio - -21,666 x -33,196 x -37,275 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - - - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - -10,935 x -28,489 x -16,148 x
Nbr of stocks (in thousands) 2 30 90 90
Reference price 2 25,000 12,500 12,500 12,500
Announcement Date 16/06/21 03/11/21 17/01/23 08/12/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023
Net sales - - - - -
EBITDA - - - - -
EBIT 1 -0.004595 -0.008737 -0.0173 -0.0339 -0.0302
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -0.004595 -0.008737 -0.0173 -0.0339 -0.0302
Net income 1 -0.004595 -0.008737 -0.0173 -0.0339 -0.0302
Net margin - - - - -
EPS - - -0.5769 -0.3766 -0.3353
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 16/06/21 16/06/21 03/11/21 17/01/23 08/12/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023
Net Debt - 0 - 0.01 0.05
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 59.8% 65% 91.9% 55.3%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - -1.140 -0.4400 -0.7700
Cash Flow per Share - - - 0 -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 16/06/21 16/06/21 03/11/21 17/01/23 08/12/23
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. JMKJ Stock
  4. Financials Coretag, Inc.